Hepatocellular Carcinoma by BCLC Stage — Trials

Hepatocellular Carcinoma by BCLC Stage — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05199285	A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab	terminated	Phase 2	15	Academic and Community Cancer Research UnitedOTHER	1	Aug 4, 2026	clinicaltrials
NCT05776875	Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC	terminated	Phase 2	3	Yale UniversityOTHER	1	Jan 15, 2025	clinicaltrials